NEWS: Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation

Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation 03 February 2017 New guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises that all hepatitis C patients should be screened for hepatitis B before starting treatment with new Direct-acting Antivirals (DAAs). If patients are infected with both viruses this does not preclude treatment but this should be […]

Read more

Answers About Grapefruit and Drug Interactions

Answers About Grapefruit and Drug Interactions     by Dr. Stephen Sinatra  Filed Under: General Health, Q&As, Heart Health  QUESTION: HOW DOES GRAPEFRUIT JUICE AND MEDICATION INTERACT? The grapefruit juice and drug interactions arise because grapefruit contains a compound called bergamottin, which blocks the action of an enzyme in the liver. (Cytochrome P450 3A4, in case you’re interested.) This enzyme is also involved in […]

Read more